Literature DB >> 22382848

Update on the biology and treatment of lymphedema.

Stanley G Rockson1.   

Abstract

OPINION STATEMENT: The past decade has produced an explosion of insights into lymphatic vascular development and structural biology and, in parallel, into the function of the lymphatics in health and in disease. In lymphedema, there is a spectrum that extends from primary (heritable) to acquired causes of disease. The diagnosis of lymphatic edema implicates a very specific treatment approach that is predicated upon the favorable impact of physiotherapy upon lymph flow and protein clearance from the edematous zones of the body. The recognition of the unique biology that accompanies lymphatic causes of edema has stimulated new research directions that are likely to translate into exciting new pharmacologic and molecular approaches to diagnosis and treatment.

Entities:  

Year:  2012        PMID: 22382848     DOI: 10.1007/s11936-012-0170-0

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  52 in total

Review 1.  Lymphatic vasculature development.

Authors:  Guillermo Oliver
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

2.  Microsurgical techniques for lymphedema treatment: derivative lymphatic-venous microsurgery.

Authors:  Corradino Campisi; Francesco Boccardo
Journal:  World J Surg       Date:  2004-06       Impact factor: 3.352

3.  Lymphatic biology and disease: is it being taught? Who is listening?

Authors:  Stanley G Rockson; Daniel N Granger; Kelley M Skeff; Wendy Chaite
Journal:  Lymphat Res Biol       Date:  2004       Impact factor: 2.589

4.  Decongestive lymphatic therapy for patients with cancer-related or primary lymphedema.

Authors:  A Szuba; J P Cooke; S Yousuf; S G Rockson
Journal:  Am J Med       Date:  2000-09       Impact factor: 4.965

Review 5.  Lymphedema.

Authors:  S G Rockson
Journal:  Am J Med       Date:  2001-03       Impact factor: 4.965

Review 6.  Current concepts and future directions in the diagnosis and management of lymphatic vascular disease.

Authors:  Stanley G Rockson
Journal:  Vasc Med       Date:  2010-06       Impact factor: 3.239

7.  Complete reduction of lymphoedema of the arm by liposuction after breast cancer.

Authors:  H Brorson; H Svensson
Journal:  Scand J Plast Reconstr Surg Hand Surg       Date:  1997-06

8.  Dynamic lymph flow imaging in patients with oedema of the lower limb for evaluation of the functional outcome after autologous lymph vessel transplantation: an 8-year follow-up study.

Authors:  Mayo Weiss; Rüdiger G H Baumeister; Klaus Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-29       Impact factor: 9.236

Review 9.  The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema.

Authors:  Andrzej Szuba; William S Shin; H William Strauss; Stanley Rockson
Journal:  J Nucl Med       Date:  2003-01       Impact factor: 10.057

10.  Digging deeper into lymphatic vessel formation in vitro and in vivo.

Authors:  Benoit Detry; Françoise Bruyère; Charlotte Erpicum; Jenny Paupert; Françoise Lamaye; Catherine Maillard; Bénédicte Lenoir; Jean-Michel Foidart; Marc Thiry; Agnès Noël
Journal:  BMC Cell Biol       Date:  2011-06-24       Impact factor: 4.241

View more
  11 in total

1.  Colonic Insult Impairs Lymph Flow, Increases Cellular Content of the Lymph, Alters Local Lymphatic Microenvironment, and Leads to Sustained Inflammation in the Rat Ileum.

Authors:  Walter Cromer; Wei Wang; Scott D Zawieja; Pierre-Yves von der Weid; M Karen Newell-Rogers; David C Zawieja
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

2.  Burn Injury-Associated MHCII+ Immune Cell Accumulation Around Lymphatic Vessels of the Mesentery and Increased Lymphatic Endothelial Permeability Are Blocked by Doxycycline Treatment.

Authors:  Walter E Cromer; Scott D Zawieja; Karen M Doersch; Hayden Stagg; Felicia Hunter; Binu Tharakan; Ed Childs; David C Zawieja
Journal:  Lymphat Res Biol       Date:  2018-01-23       Impact factor: 2.589

3.  Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema.

Authors:  Xiaochen Zhang; Justin C Brown; Electra D Paskett; Babette S Zemel; Andrea L Cheville; Kathryn H Schmitz
Journal:  Breast Cancer Res Treat       Date:  2017-04-08       Impact factor: 4.872

4.  Transient swelling versus lymphoedema in the first year following surgery for breast cancer.

Authors:  Sharon L Kilbreath; Mi-Joung Lee; Kathryn M Refshauge; Jane M Beith; Leigh C Ward; J M Simpson; D Black
Journal:  Support Care Cancer       Date:  2013-03-15       Impact factor: 3.603

5.  Blunted flow-mediated responses and diminished nitric oxide synthase expression in lymphatic thoracic ducts of a rat model of metabolic syndrome.

Authors:  Scott D Zawieja; Olga Gasheva; David C Zawieja; Mariappan Muthuchamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-12-04       Impact factor: 4.733

6.  VEGFR-3 neutralization inhibits ovarian lymphangiogenesis, follicle maturation, and murine pregnancy.

Authors:  Joseph M Rutkowski; Jong Eun Ihm; Seung Tae Lee; Witold W Kilarski; Veronique I Greenwood; Miriella C Pasquier; Alexandra Quazzola; Didier Trono; Jeffrey A Hubbell; Melody A Swartz
Journal:  Am J Pathol       Date:  2013-09-13       Impact factor: 4.307

7.  Pilot studies demonstrate the potential benefits of antiinflammatory therapy in human lymphedema.

Authors:  Stanley G Rockson; Wen Tian; Xinguo Jiang; Tatiana Kuznetsova; Francois Haddad; Jamie Zampell; Babak Mehrara; Joshua P Sampson; Leslie Roche; Jinah Kim; Mark R Nicolls
Journal:  JCI Insight       Date:  2018-10-18

8.  Local inhibition of elastase reduces EMILIN1 cleavage reactivating lymphatic vessel function in a mouse lymphoedema model.

Authors:  Eliana Pivetta; Bruna Wassermann; Lisa Del Bel Belluz; Carla Danussi; Teresa Maria Elisa Modica; Orlando Maiorani; Giulia Bosisio; Francesco Boccardo; Vincenzo Canzonieri; Alfonso Colombatti; Paola Spessotto
Journal:  Clin Sci (Lond)       Date:  2016-02-26       Impact factor: 6.124

9.  Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patients.

Authors:  Michelle J Naughton; Heshan Liu; Drew K Seisler; Jennifer Le-Rademacher; Jane M Armer; Jill M Oliveri; Jeffrey A Sloan; Karen Hock; Michael Schwartz; Gary Unzeitig; Marianne Melnik; Lisa D Yee; Gini F Fleming; John R Taylor; Charles Loprinzi; Electra D Paskett
Journal:  Cancer       Date:  2020-10-20       Impact factor: 6.860

10.  Blockade of VEGF-C and VEGF-D modulates adipose tissue inflammation and improves metabolic parameters under high-fat diet.

Authors:  Sinem Karaman; Maija Hollmén; Marius R Robciuc; Annamari Alitalo; Harri Nurmi; Bettina Morf; Dorina Buschle; H Furkan Alkan; Alexandra M Ochsenbein; Kari Alitalo; Christian Wolfrum; Michael Detmar
Journal:  Mol Metab       Date:  2014-12-04       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.